SUBSCRIBE
SUBSCRIBE
News   Policy

Eli Lilly and Company Seeks Halt On Generic Strattera Sales

August 16, 2010 | 
1 min read

NEW YORK, Aug 16 (Reuters) - Eli Lilly and Co (LLY.N) asked a federal judge on Monday to temporarily block sales of generic versions of its Strattera attention deficit disorder drug while it appeals a ruling declaring its patent invalid.

Legal
MORE ON THIS TOPIC
Pictured: A syringe broken in half with long hallway in background/Nicole Bean for BioSpace
Vaccines
Meeting of FDA’s Vaccines Advisory Panel Canceled as Kennedy Settles Into HHS
February 27, 2025
 · 
2 min read
 · 
Tristan Manalac
External view of the U.S. Capitol building
Government
Congress Re-Introduces EPIC Act to Remove IRA’s ‘Pill Penalty’
February 26, 2025
 · 
2 min read
 · 
Tristan Manalac
Loss of one drug name. Ban on a drug or its shortage. Exclusion from the list of free drugs available under the medical social program.
Drug shortages
Compounders Sue FDA for Declaring Ozempic, Wegovy Shortage Over
February 25, 2025
 · 
2 min read
 · 
Tristan Manalac
Johnson & Johnson's business center in Switzerland
Legal
J&J Takes Samsung Bioepis to Court Over ‘Unlawful’ Stelara Biosimilar Sublicense
February 25, 2025
 · 
2 min read
 · 
Tristan Manalac